These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 8713707

  • 1. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Nakamura K, Yoneda M, Kimura A, Tamori K, Yokohama S, Sato Y, Kato T, Hasegawa T, Saito H, Aoshima M, Fujita M, Makino I.
    J Gastroenterol Hepatol; 1996 Apr; 11(4):385-90. PubMed ID: 8713707
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of ursodeoxycholic acid (UDCA) therapy for compensatory liver cirrhosis on liver function tests and serum bile acid metabolism].
    Nakamura K, Aoshima M, Tani M, Kato T, Fugita M, Kimura A, Hasegawa T, Akiyama K, Makino I.
    Nihon Shokakibyo Gakkai Zasshi; 1992 Dec; 89(12):2762-70. PubMed ID: 1491464
    [Abstract] [Full Text] [Related]

  • 4. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A, Glaumann H, Strandvik B.
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [Abstract] [Full Text] [Related]

  • 5. [Conjugated bile acid profiles in serum, urine, and bile of patients with primary biliary cirrhosis under the ursodeoxycholic acid treatment].
    Aoshima M, Nakamura K, Makino I.
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):57-67. PubMed ID: 7744371
    [Abstract] [Full Text] [Related]

  • 6. Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis.
    Nakashima T, Yoh T, Sumida Y, Kakisaka Y, Mitsuyoshi H.
    J Gastroenterol Hepatol; 2001 May; 16(5):541-7. PubMed ID: 11350551
    [Abstract] [Full Text] [Related]

  • 7. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
    Beuers U, Fischer S, Spengler U, Paumgartner G.
    J Hepatol; 1991 Jul; 13(1):97-103. PubMed ID: 1918882
    [Abstract] [Full Text] [Related]

  • 8. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y, Poupon R, Gherardt MF, Chazouilleres O, Labbe D, Myara A, Trivin F.
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [Abstract] [Full Text] [Related]

  • 9. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD, Lacerda MA, Jorgensen RA, DeSotel CK, Batta AK, Salen G, Dickson ER, Rossi SS, Hofmann AF.
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [Abstract] [Full Text] [Related]

  • 10. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    Colombo C, Crosignani A, Alicandro G, Zhang W, Biffi A, Motta V, Corti F, Setchell KDR.
    J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
    [Abstract] [Full Text] [Related]

  • 11. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
    Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A.
    J Pediatr; 1990 Sep; 117(3):482-9. PubMed ID: 2391610
    [Abstract] [Full Text] [Related]

  • 12. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis.
    Marschall HU, Broomé U, Einarsson C, Alvelius G, Thomas HG, Matern S.
    J Lipid Res; 2001 May; 42(5):735-42. PubMed ID: 11352980
    [Abstract] [Full Text] [Related]

  • 13. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
    Güldütuna S, Leuschner M, Wunderlich N, Nickel A, Bhatti S, Hübner K, Leuschner U.
    Eur J Clin Pharmacol; 1993 May; 45(3):221-5. PubMed ID: 8276045
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E, Marschall HU, Winograd R, Matern S.
    Biochim Biophys Acta; 2001 Apr 03; 1526(1):44-52. PubMed ID: 11287121
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M, Colombo C, Setchell KD.
    Hepatology; 1990 Aug 03; 12(2):322-34. PubMed ID: 2391071
    [Abstract] [Full Text] [Related]

  • 16. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B, Carithers RL, Maddrey WC, Munoz S, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters MG, White H, Zetterman RK, Risser R, Rossi SS, Hofmann AF.
    Hepatology; 1999 Jun 03; 29(6):1649-54. PubMed ID: 10347103
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic liver disease with ursodeoxycholic acid.
    Guslandi M.
    J Int Med Res; 1990 Jun 03; 18(6):497-505. PubMed ID: 2292332
    [Abstract] [Full Text] [Related]

  • 18. [Effect of long-term ursodeoxycholic acid treatment on serum liver enzymes and serum bile acid metabolism in chronic hepatitis].
    Nakamura K, Akiyama K, Makino I.
    Nihon Shokakibyo Gakkai Zasshi; 1995 Jan 03; 92(1):62-71. PubMed ID: 7861628
    [Abstract] [Full Text] [Related]

  • 19. Use of ursodeoxycholic acid in patients with liver disease.
    Angulo P.
    Curr Gastroenterol Rep; 2002 Feb 03; 4(1):37-44. PubMed ID: 11825540
    [Abstract] [Full Text] [Related]

  • 20. [Bile acids in liver diseases--current indications].
    Stiehl A.
    Ther Umsch; 1995 Oct 03; 52(10):682-6. PubMed ID: 7482380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.